Angelique Van 't Wout

Title: Angelique Van 't Wout: Innovator in Antibody Research

Introduction

Angelique Van 't Wout is a prominent inventor based in Amsterdam, Netherlands. She has made significant contributions to the field of antibody research, particularly in the development of human antibodies targeting respiratory syncytial virus (RSV). With a total of two patents to her name, her work is crucial in advancing medical treatments for RSV infections.

Latest Patents

Angelique's latest patents include innovative discoveries related to human antibodies binding to the G protein of RSV. The first patent discloses isolated antibodies and antigen-binding fragments that effectively bind to the G protein of RSV, capable of neutralizing both RSV A and B subtypes. This breakthrough has important implications for the diagnosis, prophylaxis, and treatment of RSV infections. The second patent further elaborates on isolated antibodies and antigen-binding fragments that bind to the G protein of RSV, emphasizing their neutralizing capabilities.

Career Highlights

Angelique Van 't Wout is currently employed at Janssen Vaccines & Prevention B.V., where she continues her research and development efforts. Her work at this esteemed company highlights her commitment to advancing healthcare solutions through innovative research.

Collaborations

Some of her notable coworkers include Jehangir Wadia and Robert Anthony Williamson, who contribute to the collaborative environment that fosters innovation in their projects.

Conclusion

Angelique Van 't Wout is a key figure in the field of antibody research, with her patents paving the way for new treatments for RSV infections. Her contributions are vital to the ongoing efforts in medical science and public health.